Fecundity and Quality of Life of Women Treated for Solid Childhood Tumors between 1948 and 1992 in France

Sandrine Thouvenin-Doulet, Claire Berger, Léonie Casagranda, Odile Oberlin, Perrine Marec-Berard, Hélène Pacquement, Catherine Guibout, Claire Freycon, Tan Dat N'Guyen, Pierre Yves Bondiau, Anne Laprie, Delphine Berchery, Chiraz El-Fayech, Béatrice Trombert-Paviot, Florent De Vathaire

    Research output: Contribution to journalArticlepeer-review

    18 Citations (Scopus)

    Abstract

    Purpose: To describe fecundity in female survivors of childhood cancer and consider the correlation with quality of life (QOL). Materials and Methods: Of 1744 women treated for childhood cancer before the age of 15 years at one of eight French cancer treatment centers between 1948 and 1992, 1187 who were alive in 2005 were sent a self-administered questionnaire, including questions about health status, QOL (MOS SF-36), and fecundity. A standardized fecundity ratio (SFR) was calculated (SFR: observed/expected number of children) for each individual based on a national reference. Results: Of the 972 individuals (82%) who responded, 53% had at least 1 child. The overall SFR, 0.65, was dependent upon the initial diagnosis, more decreased in Central Nervous System tumors (0.24; p < 10-3) than in Germ cell (0.46; p = 0.03) or Sympathetic Nervous System tumors (0.79; p = 0.02). The average QOL motor score was 72.5 ± 19.5, and the average mental score was 61.4 ± 16.7. After adjusting for age, pathology, and self-reported sequelae in the questionnaires, it was determined that SF-36 mental (p = 0.002) and motor (p < 0.0002) scores correlated positively with fecundity, and SF-36 scores correlated negatively with locomotor late effects (p < 0.0001), growth insufficiency (p = 0.002), and psychological disorders (p < 0.001). Gonadal insufficiency was correlated with neither motor nor mental scores. Conclusion: Women treated for childhood cancer demonstrated impaired fecundity that correlated with poor QOL, as registered by the SF-36. Patients should be warned of the risk of impaired fecundity early during the follow-up. If possible, preservation of fertility should be prioritized at initiation of therapy.

    Original languageEnglish
    Pages (from-to)415-423
    Number of pages9
    JournalJournal of Adolescent and Young Adult Oncology
    Volume7
    Issue number4
    DOIs
    Publication statusPublished - 1 Aug 2018

    Keywords

    • Female survivors
    • fecundity
    • long-term follow-up
    • quality of life

    Cite this